Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies.
Juan León-RománGloria IacoboniSheila BermejoCecilia CarpioMónica BoluferClara García-CarroMario Sánchez-SalinasCarla Alonso-MartínezOriol BestardPere BarbaMaria José SolerPublished in: Clinical kidney journal (2024)
Our results suggest that AKI is a frequent but mild adverse event, with fast recovery in most patients.